Worthington Steel reported first-quarter fiscal 2027 adjusted earnings of $0.57 a share, below Wall Street’s estimate of ...
GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced new findings to be presented at the International Consortium on ...